The emerging CK2 interactome: insights into the regulation and functions of CK2 Laszlo GyenisDavid W. Litchfield OriginalPaper 14 June 2008 Pages: 5 - 14
Insights from soft X-rays: the chlorine and sulfur sub-structures of a CK2α/DRB complex Jennifer RaafOlaf-Georg IssingerKarsten Niefind OriginalPaper 08 July 2008 Pages: 15 - 23
CK2α/CK1α chimeras are sensitive to regulation by the CK2β subunit Ana JedlickiCatherine C. AllendeJorge E. Allende OriginalPaper 12 July 2008 Pages: 25 - 35
Biochemical characterization of CK2α and α′ paralogues and their derived holoenzymes: evidence for the existence of a heterotrimeric CK2α′-holoenzyme forming trimeric complexes Birgitte B. OlsenTine RasmussenOlaf-Georg Issinger OriginalPaper 24 June 2008 Pages: 37 - 47
Cell cycle and activation of CK2 Miwako Kato HommaYoshimi Homma OriginalPaper 23 July 2008 Pages: 49 - 55
A structural insight into CK2 inhibition Marco MazzoranaLorenzo A. PinnaRoberto Battistutta OriginalPaper 15 July 2008 Pages: 57 - 62
Identification of chemical inhibitors of protein-kinase CK2 subunit interaction Béatrice LaudetVirginie MoucadelClaude Cochet OriginalPaper 14 June 2008 Pages: 63 - 69
Expanding the chemical diversity of CK2 inhibitors Renaud PrudentVirginie MoucadelClaude Cochet OriginalPaper 18 June 2008 Pages: 71 - 85
New inhibitors of protein kinase CK2, analogues of benzimidazole and benzotriazole Maria BretnerAndzelika Najda-BernatowiczAndrzej Sapota OriginalPaper 12 June 2008 Pages: 87 - 89
Impact of protein kinase CK2 on inhibitor of apoptosis proteins in prostate cancer cells Guixia WangKashif A. AhmadKhalil Ahmed OriginalPaper 24 June 2008 Pages: 91 - 97
Transcription factor TAFII250 phosphorylates the acidic domain of Mdm2 through recruitment of protein kinase CK2 Nerea Allende-VegaLynsey McKenzieDavid Meek OriginalPaper 12 June 2008 Pages: 99 - 106
Protein kinase CK2 and cell polarity Alexandre DeshièreNathalie Theis-FebvreOdile Filhol OriginalPaper 28 June 2008 Pages: 107 - 113
Ability of CK2β to selectively regulate cellular protein kinases Birgitte B. OlsenBarbara Guerra OriginalPaper 17 June 2008 Pages: 115 - 126
Evaluating CK2 activity with the antibody specific for the CK2-phosphorylated form of a kinase-targeting cochaperone Cdc37 Yoshihiko MiyataEisuke Nishida OriginalPaper 20 June 2008 Pages: 127 - 134
Examination of transcript amounts and activity of protein kinase CK2 in muscle lysates of different types of human muscle pathologies Dieter HeussJanine KlascinskiSaid Hashemolhosseini OriginalPaper 14 June 2008 Pages: 135 - 140
Gene targeting of CK2 catalytic subunits David C. SeldinDavid Y. LouIsabel Dominguez OriginalPaper 02 July 2008 Pages: 141 - 147
CK2 mediates phosphorylation and ubiquitin-mediated degradation of the PML tumor suppressor P. P. ScaglioniT. M. YungP. P. Pandolfi OriginalPaper 20 June 2008 Pages: 149 - 154
Comparative analysis of CK2 expression and function in tumor cell lines displaying sensitivity vs. resistance to chemical induced apoptosis Giovanni Di MairaFrancesca BrustolonMaria Ruzzene OriginalPaper 17 June 2008 Pages: 155 - 161
CIGB-300, a novel proapoptotic peptide that impairs the CK2 phosphorylation and exhibits anticancer properties both in vitro and in vivo Silvio E. PereaOsvaldo ReyesBoris Acevedo OriginalPaper 25 June 2008 Pages: 163 - 167
Cystic fibrosis as a bowel cancer syndrome and the potential role of CK2 Anil Mehta OriginalPaper Open access 05 July 2008 Pages: 169 - 175
Inhibition of protein kinase CK2 suppresses angiogenesis and hematopoietic stem cell recruitment to retinal neovascularization sites A. A. KramerovM. SaghizadehA. V. Ljubimov OriginalPaper 09 July 2008 Pages: 177 - 186
Contribution of the individual subunits of protein kinase CK2 and of hPrp3p to the splicing process Janka DörrSabine KartariusMathias Montenarh OriginalPaper 14 June 2008 Pages: 187 - 193
